⌘K

Login Start Free

Home/Filings/4/0001209191-22-038612

4//SEC Filing

Garfield Greg Shaw 4

Accession 0001209191-22-038612

CIK 0001528287other

View on SEC.gov Company Profile

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 9:12 PM ET

Size

5.3 KB

Accession

0001209191-22-038612

Insider Transaction Report

Form 4

Period: 2022-06-13

NeuroPace IncNPCE

Garfield Greg Shaw

Director

Transactions

Award
Stock Option (Right to Buy)
2022-06-13+18,253→ 18,253 total
Exercise: $6.30Exp: 2032-06-12→ Common Stock (18,253 underlying)

Footnotes (1)

[F1]The shares subject to the option shall vest in twelve (12) equal consecutive monthly installments until all of the option shares are fully vested and exercisable.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

NeuroPace Inc

CIK 0001528287

Entity typeother

Related Parties

1

filerCIK 0001594406

Filing Metadata

Form type: 4
Filed: Jun 20, 8:00 PM ET
Accepted: Jun 21, 9:12 PM ET
Size: 5.3 KB

View on SEC.gov